BRENNER RANDALL B. (Chief Development & Regulatory) reported 2 transactions at PARATEK PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/21/2023ACC: 0000899243-23-019365
Officer· Chief Development & Regulatory
Since Sep 2019
-415.21K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
415.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−329.71K
Price / share
—
Trade value
—
% of position
79.4%
9/21/2023
415.21K→85.50K
Common Stock
Direct
Shares
−85.50K
Price / share
—
Trade value
—
% of position
New position
9/21/2023
85.50K→0.00
Total
Net shares
−415.21K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/21/2023 | D · Disposition | −329.71K | — | — | 79.4% | 415.21K | 85.50K |
| Common Stock Direct | 9/21/2023 | D · Disposition | −85.50K | — | — | New position | 85.50K | 0.00 |
| Total | −415.21K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported